Sufentanil NanoTab PCA System/15 mcg

DRUG4 trials

Sponsors

Talphera, Inc

Conditions

Pain, PostoperativePost Operative PainPost-Operative Pain

Phase 2

An Open-Label Functionality, Safety and Efficacy Study in Patients Undergoing Elective Unilateral Knee Replacement

CompletedNCT00859313

Talphera, IncPain, Postoperative

Start: 2009-04-30End: 2009-08-31Updated: 2012-03-01

Phase 3

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery

CompletedNCT01539642

Talphera, IncPost-Operative Pain

Start: 2012-02-29End: 2013-02-28Updated: 2015-10-20

A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™)to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain

CompletedNCT01539538

Talphera, IncPost-Operative Pain

Start: 2012-04-30End: 2012-12-31Updated: 2015-10-01

Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After Knee or Hip Replacement Surgery

CompletedNCT01660763

Talphera, IncPost Operative Pain

Start: 2012-08-31End: 2013-05-31Updated: 2015-10-20